We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

26 hedge funds and large institutions have $9.03M invested in TriSalus Life Sciences in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

54% more capital invested

Capital invested by funds: $5.85M → $9.03M (+$3.18M)

37% more funds holding

Funds holding: 19 → 26 (+7)

0.89% more ownership

Funds ownership: 2.62% → 3.51% (+0.89%)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DFO
Duquesne Family Office
New York
+$2.92M
2
Goldman Sachs
Goldman Sachs
New York
+$503K
3
BlackRock
BlackRock
New York
+$378K
4
Millennium Management
Millennium Management
New York
+$163K
5
JP Morgan Chase
JP Morgan Chase
New York
+$97.5K

Top Sellers

Rank Fund Capital Flow
1
HA
HC Advisors
Georgia
-$860K
2
HF
HRT Financial
New York
-$405K
3
TWP
Tyche Wealth Partners
Texas
-$154K
4
UBS Group
UBS Group
Switzerland
-$152K
5
Creative Planning
Creative Planning
Kansas
-$137K
Name Holding Trade Value Shares
Change 		Change in
Stake
DFO
1
Duquesne Family Office
New York
$3.08M +$2.92M +315,955 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.63M +$18.7K +2,023 +1%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.31M +$77K +8,337 +7%
Goldman Sachs
4
Goldman Sachs
New York
$531K +$503K +54,475 New
CWM
5
Connecticut Wealth Management
Connecticut
$435K -$116K -12,582 -22%
BlackRock
6
BlackRock
New York
$411K +$378K +40,900 +3,220%
LNWWM
7
Laird Norton Wetherby Wealth Management
California
$341K – – –
Northern Trust
8
Northern Trust
Illinois
$277K +$94.5K +10,233 +56%
AC
9
Anson Capital
Georgia
$238K -$97.7K -10,590 -30%
Millennium Management
10
Millennium Management
New York
$173K +$163K +17,696 New
Cambridge Investment Research Advisors
11
Cambridge Investment Research Advisors
Iowa
$152K – – –
Morgan Stanley
12
Morgan Stanley
New York
$130K -$108K -11,669 -47%
JP Morgan Chase
13
JP Morgan Chase
New York
$103K +$97.5K +10,559 New
TWP
14
Tyche Wealth Partners
Texas
$97.5K -$154K -16,664 -62%
Qube Research & Technologies (QRT)
15
Qube Research & Technologies (QRT)
United Kingdom
$53.5K +$50.7K +5,490 New
Bank of America
16
Bank of America
North Carolina
$21.1K +$20K +2,168 New
TRCT
17
Tower Research Capital (TRC)
New York
$15K -$3.98K -431 -22%
Wells Fargo
18
Wells Fargo
California
$12.9K +$18 +2 +0.2%
HRC
19
Hoertkorn Richard Charles
$6.51K – – –
GWSG
20
GPS Wealth Strategies Group
Colorado
$6.41K – – –
JFG
21
JDM Financial Group
Texas
$5.17K +$4.89K +530 New
UBS Group
22
UBS Group
Switzerland
$3.81K -$152K -16,424 -98%
S
23
SignatureFD
Georgia
$975 +$923 +100 New
DM
24
Deerfield Management
New York
$10 – – –
CS
25
Clear Street
New York
$10 +$9 +1 New
1
2

TLSI Hedge Fund Activity: Q1 2024 in Review

26 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2024, worth a combined $9.03M — up 54% from $5.85M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TLSI positions and 3 closed out — a net gain of 7 holders — while 5 added to existing stakes and 6 trimmed.

The largest buyer was Duquesne Family Office, opening a new position worth an estimated $2.92M. The largest seller was HC Advisors, exiting entirely with an estimated $860K sold.

  • 26 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2024, up from 19 in Q4 2023.
  • Funds reported $9.03M of TriSalus Life Sciences stock for Q1 2024, up 54% quarter-over-quarter.
  • 10 funds opened new TriSalus Life Sciences positions in Q1 2024 and 3 closed out, a net change of +7 holders.
  • The largest TriSalus Life Sciences buyer in Q1 2024 was Duquesne Family Office, an estimated $2.92M added.
  • The largest TriSalus Life Sciences seller in Q1 2024 was HC Advisors, an estimated $860K sold.

Based on aggregated 13F filings for Q1 2024.